Today on DrugResearcher.com
 
Boehringer hopes cash injection will turbocharge diabetes and obesity programme

Wyeth ups the ante with new proteomics method

Orexo buys Biolipox for pain pipeline

Roche results up on oncology portfolio

Galapagos gains grants of €5.2m

 
   
Related Industry News
 
Pfizer gets chatty with docs online

Results: 2007 European outsourcing awards

US dragging its heels on biosimilars, says report

Paving the way to next generation biologics

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Tuesday 16 October 2007 Forward to a colleague

Company Profile

ChiralCHIRALPAK® IC

CHIRAL TECHNOLOGIES EUROPE announce the launch of CHIRALPAK® IC. The combination of CHIRALPAK® IA , IB and now IC provides a screening set of columns with exceptionally high success rates. The chiral separation of > 99% of all small molecules is attained using just... Click Here

Access Full Stories



Boehringer hopes cash injection will turbocharge diabetes and obesity programme
Boehringer Ingelheim has witnessed Vitae Pharmaceuticals attack the same diabetes and obesity target as itself, only faster, and has decided to splash out for a piece of the action... Read


Wyeth ups the ante with new proteomics method
Researchers from Wyeth Research's Biological Technologies division have described how the use of a titania-affinity enrichment step can aid in the discovery of post-translational protein modifications... Read


Orexo buys Biolipox for pain pipeline
Drug formulation and delivery specialist Orexo has decided it has had enough of improving established drugs and wants to develop its own, so has bought speciality pharma firm Biolipox... Read


Roche results up on oncology portfolio
Roche announced its third quarter financials today, with its portfolio of oncology products such as Herceptin (trastuzumab) and Avastin (bevacizumab) performing strongly, and helping off-set the massive 60 per... Read


Galapagos gains grants of €5.2m
Galapagos and its services division BioFocus DPI have gained three new research grants totalling €5.2m... Read


All News Headlines for:
October | September | August

ESA BioSciencesTechnical / White Paper

Manufacturing Variations in Polysorbate Batches

Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here

Related Industry News



Pfizer gets chatty with docs online
Pfizer has gone where no pharmaceutical company has gone before - a social networking website... Read


Results: 2007 European outsourcing awards
The ten winners of the European outsourcing awards for 2007 were finally unveiled at the recently-held CPhI trade show in Milan... Read


US dragging its heels on biosimilars, says report
The US is woefully lagging behind the EU when it comes to approving biosimilars, a new report says... Read


Paving the way to next generation biologics
As biologic drugs become ever more prominent, Avecia Biologics is winning plaudits for its advanced protein expression system pAVEway, gaining recognition from international industry experts and investing to meet... Read


Weekly Comment

Pharmaceuticals is top R&D spender

As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development. Read



Successful separations - 'A Mini-tutorial to HILI'Application Notes

Separation of polar compounds

A Mini-tutorial to HILIC The ZIC®-HILIC column is the ideal choice for separation of polar and hydrophilic compounds. Amino acids, bases, peptides, carbohydrates, plant extracts and other polar compounds have good retention on the column from SeQuant - "The Number... Click Here
Previous Headlines



GSK's disdain is blatant over new rules for patent
GlaxoSmithkline (GSK) has expressed its disdain for looming changes to drug patent application rules in the US and has launched a lawsuit to try and stop them coming into force next month... Read


Improved infrastructure key to cheaper drugs
Improving the technology infrastructure of drug development could save the industry hundreds of millions of dollars, according to a new US government study, with the ultimate winners being patients... Read


Negative credit ratings puts US pharma in glum Moody
Moody's Investors Service believes that things are set to get worse for the US pharma industry and has revised is credit ratings outlook from stable to negative... Read


The death of PCR for sequencing amplification?
Two new techniques have been developed that could signal the end of PCR (polymerase chain reaction) amplification for sequencing applications and dramatically increase the efficiency of sample preparation... Read


Billionaire 'raider' circles as Biogen put up for sale
Biogen Idec has announced it is seeking a buyer for the company and has already received several expressions of interest - including a reputed $23bn (€16.2bn) bid from billionaire corporate raider Carl Icahn... Read

Technical / White Papers, Case studies, Web casts
Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
DAICEL chiral chromatography products - Company Profile

Rapid HPLC method development with ChromSword®Auto software - Product Presentation

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com